Innovation Insider
SEPTEMBER 2021
|
|
TAKEAWAYS FROM THE
U.S. INNOVATION COMPETITIVENESS SUMMIT
CO-HOSTED BY UK INNOVATE
|
|
The U.S. Innovation Competitiveness Summit was held virtually last week with thousands taking part in sessions on boosting innovation, intellectual property, tech transfer and innovations, and expanding frontiers in funding innovation.
The University of Kentucky (UK) was well-represented with President Capilouto being part of the kick-off by providing welcoming remarks and Ian McClure, AVPR, Innovation & Economic Development and Executive Director, UK Innovate, moderating a panel on "Redistributing the Innovation Landscape: Creating New Regional Technology Hubs" with Dr. Lisa Cassis, VP for Research, UK as one of the panelists.
Kentucky Governor Beshear also provided a keynote address.
You can check out Governor Beshear's Keynote (47:39 in video) and President Capilouto's Welcoming Remarks (5:50 in video), our UK-hosted webinar, and all the other sessions by clicking the links below.
|
|
LAUNCH BLUE UACCEL FALL COHORT 2021 ANNOUNCED |
|
Launch Blue announced a record thirteen technologies from Kentucky universities have been selected to participate in their fall cohort. UAccel provides professional development and experiential learning opportunities to University of Kentucky (UK) and Kentucky Commercialization Ventures (KCV) innovators that are interested in learning the best commercialization path for their technology.
Applications for the Spring 2022 UAccel cohort will open in November 2021.
|
|
ANNOUNCING THE KENTUCKY INTELLECTUAL PROPERTY ALLIANCE |
|
KICK-OFF EVENT
Friday, October 1, 2021
10:00 - 11:00 a.m. ET
Via Zoom
|
|
In September, Kentucky Science and Technology Corporation (KSTC), Kentucky Commercialization Ventures (KCV), and several other partners, including UK Innovate, announced the launch of the Kentucky Intellectual Property Alliance (KYIPA). Kentucky is one of the first 10 states to launch such an Alliance under the U.S. Intellectual Property Alliance iniatitiave. KYIPA collaborates to celebrate innovation, educate on matters related to IP, and increase access to IP legal protection statewide.
KYIPA is hosting a kick-off event with special guests.
Host:
- Monique Quarterman, Executive Advisory Committee Member, KYIPA and Executive Director, KCV
Special Guests:
- Scott Frank, President & CEO, AT&T Intellectual Property, LLC and Founder, Chair & President, U.S. IP Alliance
- Judge Paul Michel, Retired Chief Justice, U.S. Court of Appeals for the Federal Circuit and Vice Chair, U.S. IP Alliance
- David Kappos, Former Director, USPTO, Former Chief IP Counsel, IBM and Vice Chair, U.S. IP Alliance
Moderator:
- Ian McClure, Associate Vice President for Research, Innovation and Economic Impact, and Executive Director, UK Innovate
Register NOW for this free, statewide launch event!
|
|
Commercialization Manager
Office of Technology Commercialization
|
This position will support technologies in drug discovery and drug development, identify commercialization partnership targets and/or potential startup team members, and assess and pursue market feedback and commercialization opportunities.
DEADLINE TO APPLY: 09/30/2021
|
|
Administrative Assistant
Office of Technology Commercialization
|
This position will be the point of contact for OTC, have oversight and management of the director's calendar and provide operational support.
(This is a part-time position.)
DEADLINE TO APPLY: 09/30/2021
|
|
UK INNOVATORS RECEIVE FUNDING FROM KYNETIC CYCLE 3 |
|
Congratulations to the University of Kentucky innovators who received funding in KYNETIC's Cycle 3. Each innovator is receiving $50,000 in this cycle.
- "A Novel Therapeutic Target for Hepatic Lipid Accumulation" (Scott Gordon, College of Medicine )
- "Development of Novel VMAT2 Inhibitors for the Treatment of Methamphetamine Use Disorder" (Jared Hammill, College of Pharmacy)
- "Power Driven Bone Biopsy Trephine Needle System" (Clay Larkin, College of Medicine (under Dr. Madhumathi Rao)
- "Use of Antisense Oligonucleotides Targeted Against Angiotensinogen in Marfan Syndrome" (Mary Sheppard, College of Medicine)
- "A Highly Selective mPGES-1 Inhibitor as an Effective and Non-Addictive Analgesic" (Fang Zheng, College of Pharmacy)
|
|
 |
Catheter Port for Intrathecal and Intracranial Administration of Chemotherapy |
UK researchers have developed a novel catheter port with a trocar that allows the catheter to attach directly to the port without the need for external reinforcement. This design requires significantly less manipulation of the catheter after it is placed, which reduces the risk of the catheter being pulled out of the ventricle during attachment to the drug reservoir.
This technology is safer and poses less risk to patients, allows the catheter to attach directly to the drug reservoir, requires less manipulation for placement, and does not require external reinforcement.
|
|
|
|
|
Keith R. Pennypacker, PhD, Professor, Interim Director of the Center for Advanced Translational Stroke Science, Department of Neurology, College of Medicine, University of Kentucky.
Keith created UK startup Cerelux, LLC, which utilizes his project, "The Blood And Clot Thrombectomy Registry And Collaboration (BACTRAC), to develop biomarkers for clinical outcomes and identify molecular targets for therapeutic adjuvant treatments to be used in conjunction with the thrombectomy procedure."
|
|
|
|
Cerelux, LLC's mission is "to improve the prognosis of stroke patients by developing innovative diagnostics and therapies."
Cerelux, LLC is "discovering in-vitro diagnostics and adjuvant therapies by investigating the cellular/molecular events occurring during a stroke in the vicinity of the infarct by accessing samples from stroke patients during mechanical thrombectomy procedures."
Cerelux, LLC has created "a biobank which includes blood and thrombus samples directly from the brain. These samples provide insight into the early molecular events occurring in stroke to discover 1) biomarkers to predict clinical outcomes and 2) therapeutic targets for adjuvant treatments for the thrombectomy procedure."
|
|
|
|
"miRNA for treatment of breast cancer"
Pharmaceutical Sciences
"Polysiloxane binders"
Susan Odom, Yang-Tse Cheng
Chemistry
Chemical & Materials Engineering
"Mutants of cocaine esterase"
Chang-Guo Zhan
Pharmaceutical Sciences
|
|
"Combination of a DNA condensation-inducing compound and an EIS inhibitor for antibiotic treatment"
Sylvie-Garneau Tsodikova
Pharmaceutical Sciences
"Methods of treating pain and/or inflammatory disorders using lapatinib"
Chang-Guo Zhan, Fang Zheng
Pharmaceutical Sciences
"Compositions and methods for enhancing neuro-repair"
Florin Despa, Larry B Goldstein
Pharmacology & Nutritional Sciences
Neurology
|
|
|
LICENSES & OPTIONS
AUGUST 2021
|
|
AmDx PrognostX, Inc
Florin Despa, Kenneth Margulies, Larry Goldstein, Nirmal Verma
Pharmacology & Nutritional Sciences
Neurology
|
|
TECHSTARS STARTUP WEEK LOUISVILLE
September 20-23, 2021
|
|
"TechStars Startup Week Louisville is a five-day celebration of our community that builds momentum and opportunity around entrepreneurship." |
|
STATE OF KENTUCKY UNIVERSITY COMMERCIALIZATION
Wednesday, September 22
1-2:00 p.m. ET
Panelists:
- Ian McClure, AVPR, Innovation and Economic Impact, and Executive Director, UK Innovate, University of Kentucky
- Monique Quarterman, Executive Director, Kentucky Commercialization Ventures
- Allen Morris, Executive Director, Commercialization EPI-Center, University of Louisville
- Taunya Phillips, Director, Office of Technology Commercialization, University of Kentucky
|
|
UNIVERSITY OF INNOVATION, FUNDING TECHNOLOGIES, & PAYING IT FORWARD FOR FUTURE FOUNDERS
Thursday, September 23
9-10:00 a.m. ET
Panelists:
- Ian McClure, AVPR, Innovation and Economic Impact, and Executive Director, UK Innovate, University of Kentucky
- Bryce Butler, Managing Director, Access Ventures
- Landon Young, Executive Director of University Initiatives, Elevate Ventures
- Natalia Bishop, Director of Innovation & Entrepreneurship, University of Louisville
|
|
|
LAUNCH BLUE VIRTUAL SBIR LAB
October 7
8:30 am - 5:40 pm ET
|
Launch Blue is hosting a virtual SBIR Lab on October 7 that aims to help SBIR/STTR applicants and awardees develop high-level commercialization strategies around their technology. Companies with strong commercialization strategies are more fundable at the next grant stage, competitive candidates for private capital investment, attractive to strategic partners, and more successful long term.
Join us for this virtual lab for a day packed with sessions led by founders, innovators, and investors sharing their real-world expertise using SBIR to launch startups. Sponsored by the Kentucky Cabinet for Economic Development, there will be a special lunch presentation about Kentucky’s nationally recognized SBIR Matching Funds program. The day will end with a casual networking session, with breakout rooms hosted by presenters and service providers.
Early bird tickets are now on sale at $99 per person. Kentucky-based founders are eligible for a discounted rate, email us at x@launchblue.org for more information.
|
|
|
|
Every Wednesday, 8:00 - 9:00 am ET
Virtual
|
|
Every Wednesday, 12:00 pm ET
Virtual
|
|
|
Every Friday, 12:30 - 1:30 pm ET
Virtual
|
|
Friday, September 24, 9:00 am - 5:00 pm ET
110 W Vine Street & 249 E Main Street
|
|
|
Wednesday, October 6, 5:00 - 7:00 p.m. ET Lyric Theatre, 200 E Third Street, Lexington
|
|
Thursday, October 21, 4:00 - 5:00 pm ET
Virtual
|
|
|
Thursday, October 21, 4:00 - 6:00 pm ET
Virtual
|
|
Wednesday, October 25, 3:15 - 5:00 p.m. ET
|
|
|
Organized by the Center for Computational Sciences & ITS-RCI
October 19 & 20
University of Kentucky Gatton Student Center
160 Avenue of Champions, Lexington
|
|
|
|
|
|
|
